Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 13 May 2019 for Novelion Therapeutics Inc., €169.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Roger Louis: trading record in brief
All filings by Roger Louis on record concern Novelion Therapeutics Inc. Over a trading history stretching from 9 May 2017 to 9 May 2019, the count stands at 4 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 13 May 2019 with a share grant (€169) in Novelion Therapeutics Inc. Between a trade and the moment it shows up on SEDI, the median delay is 2 days. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Companies and markets linked to Roger Louis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
155 shares@ US$1.2222.5% of flowCommon StockSEC:0001104659-19-028902:0
161 shares@ US$4.2626.9% of flowCommon StockSEC:0001104659-18-032525:0
162 shares@ US$9.4265.2% of flowCommon SharesSEC:0001104659-17-031892:1
547 sharesCommon SharesSEC:0001104659-17-031892:0
4 of 4 declarations
